Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort.

Cumming SA, Jimenez-Moreno C, Okkersen K, Wenninger S, Daidj F, Hogarth F, Littleford R, Gorman G, Bassez G, Schoser B, Lochmüller H, van Engelen BGM, Monckton DG; OPTIMISTIC Consortium.

Neurology. 2019 Sep 3;93(10):e995-e1009. doi: 10.1212/WNL.0000000000008056. Epub 2019 Aug 8.

PMID:
31395669
2.

Performance Streaks in Elite Beach Volleyball - Does Failure in One Sideout Affect Attacking in the Next?

Link D, Wenninger S.

Front Psychol. 2019 Apr 30;10:919. doi: 10.3389/fpsyg.2019.00919. eCollection 2019.

3.

Cannabis use in myotonic dystrophy patients in Germany and USA: a pilot survey.

Montagnese F, White M, Klein A, Stahl K, Wenninger S, Schoser B.

J Neurol. 2019 Feb;266(2):530-532. doi: 10.1007/s00415-018-9159-2. Epub 2018 Dec 15. No abstract available.

PMID:
30552503
4.

Safety and efficacy of short- and long-term inspiratory muscle training in late-onset Pompe disease (LOPD): a pilot study.

Wenninger S, Greckl E, Babačić H, Stahl K, Schoser B.

J Neurol. 2019 Jan;266(1):133-147. doi: 10.1007/s00415-018-9112-4. Epub 2018 Nov 14.

PMID:
30430231
5.

Evidence of mild founder LMOD3 mutations causing nemaline myopathy 10 in Germany and Austria.

Schatz UA, Weiss S, Wenninger S, Schoser B, Muss WH, Bittner RE, Schmidt WM, Schossig AS, Rudnik-Schöneborn S, Baumann M.

Neurology. 2018 Oct 30;91(18):e1690-e1694. doi: 10.1212/WNL.0000000000006428. Epub 2018 Oct 5.

PMID:
30291184
6.

How to Interpret Abnormal Findings of Spirometry and Manometry in Myotonic Dystrophies?

Babačić H, Goldina O, Stahl K, Montagnese F, Jurinović V, Schoser B, Wenninger S.

J Neuromuscul Dis. 2018;5(4):451-459. doi: 10.3233/JND-180331.

PMID:
30282374
7.

[Anti-IgLON5 syndrome - what is our current understanding?]

Wenninger S, Schoser B.

Fortschr Neurol Psychiatr. 2018 Sep;86(9):559-565. doi: 10.1055/a-0665-4593. Epub 2018 Sep 26. Review. German. Erratum in: Fortschr Neurol Psychiatr. 2018 Sep;86(9):E1.

PMID:
30257262
8.

[Myasthenia gravis: current status of antibody diagnostics and aspects on refractory myasthenia gravis].

Wenninger S, Schoser B.

Fortschr Neurol Psychiatr. 2018 Sep;86(9):551-558. doi: 10.1055/a-0624-9397. Epub 2018 Sep 24. Review. German.

PMID:
30248688
9.

Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial.

Okkersen K, Jimenez-Moreno C, Wenninger S, Daidj F, Glennon J, Cumming S, Littleford R, Monckton DG, Lochmüller H, Catt M, Faber CG, Hapca A, Donnan PT, Gorman G, Bassez G, Schoser B, Knoop H, Treweek S, van Engelen BGM; OPTIMISTIC consortium.

Lancet Neurol. 2018 Aug;17(8):671-680. doi: 10.1016/S1474-4422(18)30203-5. Epub 2018 Jun 19.

PMID:
29934199
10.

Core Clinical Phenotypes in Myotonic Dystrophies.

Wenninger S, Montagnese F, Schoser B.

Front Neurol. 2018 May 2;9:303. doi: 10.3389/fneur.2018.00303. eCollection 2018. Review.

11.

Falls and resulting fractures in Myotonic Dystrophy: Results from a multinational retrospective survey.

Jiménez-Moreno AC, Raaphorst J, Babačić H, Wood L, van Engelen B, Lochmüller H, Schoser B, Wenninger S.

Neuromuscul Disord. 2018 Mar;28(3):229-235. doi: 10.1016/j.nmd.2017.12.010. Epub 2017 Dec 27.

PMID:
29361394
12.

Expanding the Clinical Spectrum of IgLON5-Syndrome.

Wenninger S.

J Neuromuscul Dis. 2017;4(4):337-339. doi: 10.3233/JND-170259.

PMID:
29103046
13.

Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2.

Montagnese F, Mondello S, Wenninger S, Kress W, Schoser B.

J Neurol. 2017 Dec;264(12):2472-2480. doi: 10.1007/s00415-017-8653-2. Epub 2017 Oct 30.

PMID:
29086017
14.

Respiratory involvement in neuromuscular disorders.

Boentert M, Wenninger S, Sansone VA.

Curr Opin Neurol. 2017 Oct;30(5):529-537. doi: 10.1097/WCO.0000000000000470. Review.

PMID:
28562381
15.

Practical Recommendations for Diagnosis and Management of Respiratory Muscle Weakness in Late-Onset Pompe Disease.

Boentert M, Prigent H, Várdi K, Jones HN, Mellies U, Simonds AK, Wenninger S, Barrot Cortés E, Confalonieri M.

Int J Mol Sci. 2016 Oct 17;17(10). pii: E1735. Review.

16.

Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study.

van der Ploeg A, Carlier PG, Carlier RY, Kissel JT, Schoser B, Wenninger S, Pestronk A, Barohn RJ, Dimachkie MM, Goker-Alpan O, Mozaffar T, Pena LD, Simmons Z, Straub V, Guglieri M, Young P, Boentert M, Baudin PY, Wens S, Shafi R, Bjartmar C, Thurberg BL.

Mol Genet Metab. 2016 Sep;119(1-2):115-23. doi: 10.1016/j.ymgme.2016.05.013. Epub 2016 May 19.

17.

Importance of latrine communication in European rabbits shifts along a rural-to-urban gradient.

Ziege M, Bierbach D, Bischoff S, Brandt AL, Brix M, Greshake B, Merker S, Wenninger S, Wronski T, Plath M.

BMC Ecol. 2016 Jun 14;16:29. doi: 10.1186/s12898-016-0083-y.

18.

Long-term whole-body vibration training in two late-onset Pompe disease patients.

Montagnese F, Thiele S, Wenninger S, Schoser B.

Neurol Sci. 2016 Aug;37(8):1357-60. doi: 10.1007/s10072-016-2612-z. Epub 2016 May 18.

PMID:
27193587
19.

Prevalence of Pompe disease in 3,076 patients with hyperCKemia and limb-girdle muscular weakness.

Lukacs Z, Nieves Cobos P, Wenninger S, Willis TA, Guglieri M, Roberts M, Quinlivan R, Hilton-Jones D, Evangelista T, Zierz S, Schlotter-Weigel B, Walter MC, Reilich P, Klopstock T, Deschauer M, Straub V, Müller-Felber W, Schoser B.

Neurology. 2016 Jul 19;87(3):295-8. doi: 10.1212/WNL.0000000000002758. Epub 2016 May 11.

20.

[Educational and Professional Qualifications of Adults With Myotonic Dystrophies - A Misleading Perception by the Myopathic Face?].

Stahl K, Wenninger S, Schüller A, Montagnese F, Schoser B.

Fortschr Neurol Psychiatr. 2016 Apr;84(4):211-6. doi: 10.1055/s-0042-104193. Epub 2016 Apr 21. German.

PMID:
27100845
21.

Utility of a next-generation sequencing-based gene panel investigation in German patients with genetically unclassified limb-girdle muscular dystrophy.

Kuhn M, Gläser D, Joshi PR, Zierz S, Wenninger S, Schoser B, Deschauer M.

J Neurol. 2016 Apr;263(4):743-50. doi: 10.1007/s00415-016-8036-0. Epub 2016 Feb 17.

PMID:
26886200
22.

"Orbiting around" the orbital myositis: clinical features, differential diagnosis and therapy.

Montagnese F, Wenninger S, Schoser B.

J Neurol. 2016 Apr;263(4):631-40. doi: 10.1007/s00415-015-7926-x. Epub 2015 Oct 17. Review.

PMID:
26477021
23.

[The Spectrum of Neuromyotonia: Clinics, Therapy and Outcome].

Wenninger S, Schoser B.

Fortschr Neurol Psychiatr. 2015 Aug;83(8):457-62. doi: 10.1055/s-0035-1553512. Epub 2015 Sep 1. German.

PMID:
26327478
24.

Homozygosity for the common GAA gene splice site mutation c.-32-13T>G in Pompe disease is associated with the classical adult phenotypical spectrum.

Musumeci O, Thieme A, Claeys KG, Wenninger S, Kley RA, Kuhn M, Lukacs Z, Deschauer M, Gaeta M, Toscano A, Gläser D, Schoser B.

Neuromuscul Disord. 2015 Sep;25(9):719-24. doi: 10.1016/j.nmd.2015.07.002. Epub 2015 Jul 10.

PMID:
26231297
25.

Sleep-related symptoms and sleep-disordered breathing in adult Pompe disease.

Boentert M, Karabul N, Wenninger S, Stubbe-Dräger B, Mengel E, Schoser B, Young P.

Eur J Neurol. 2015 Feb;22(2):369-76, e27. doi: 10.1111/ene.12582. Epub 2014 Nov 4.

PMID:
25367349
26.

Urge incontinence and gastrointestinal symptoms in adult patients with pompe disease: a cross-sectional survey.

Karabul N, Skudlarek A, Berndt J, Kornblum C, Kley RA, Wenninger S, Tiling N, Mengel E, Plöckinger U, Vorgerd M, Deschauer M, Schoser B, Hanisch F.

JIMD Rep. 2014;17:53-61. doi: 10.1007/8904_2014_334. Epub 2014 Aug 26.

27.

Pregnancy and delivery in women with Pompe disease.

Karabul N, Berndt J, Kornblum C, Kley RA, Wenninger S, Tiling N, Mengel E, Plöckinger U, Vorgerd M, Deschauer M, Schoser B, Hanisch F.

Mol Genet Metab. 2014 Jun;112(2):148-53. doi: 10.1016/j.ymgme.2014.03.010. Epub 2014 Mar 30.

PMID:
24726296
28.

The impact of antibodies in late-onset Pompe disease: a case series and literature review.

Patel TT, Banugaria SG, Case LE, Wenninger S, Schoser B, Kishnani PS.

Mol Genet Metab. 2012 Jul;106(3):301-9. doi: 10.1016/j.ymgme.2012.04.027. Epub 2012 May 9.

PMID:
22613277
29.

Toward deconstructing the phenotype of late-onset Pompe disease.

Schüller A, Wenninger S, Strigl-Pill N, Schoser B.

Am J Med Genet C Semin Med Genet. 2012 Feb 15;160C(1):80-8. doi: 10.1002/ajmg.c.31322. Epub 2012 Jan 17.

PMID:
22253010
30.

[Congenital and endogenous endocrine myopathy].

Wenninger S, Schoser B.

Z Rheumatol. 2011 Nov;70(9):760-2, 764-6. doi: 10.1007/s00393-011-0787-5. German.

PMID:
21904835
31.

Impact of state and trait anxiety on the panic response to CCK-4.

Eser D, Wenninger S, Baghai T, Schüle C, Rupprecht R.

J Neural Transm (Vienna). 2008 Jun;115(6):917-20. doi: 10.1007/s00702-008-0047-2. Epub 2008 Apr 15.

PMID:
18414777
32.

Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers.

Eser D, Leicht G, Lutz J, Wenninger S, Kirsch V, Schüle C, Karch S, Baghai T, Pogarell O, Born C, Rupprecht R, Mulert C.

Hum Brain Mapp. 2009 Feb;30(2):511-22.

PMID:
18095276
33.

Three-dimensional tissue structure affects sensitivity of fibroblasts to TGF-beta 1.

Kunz-Schughart LA, Wenninger S, Neumeier T, Seidl P, Knuechel R.

Am J Physiol Cell Physiol. 2003 Jan;284(1):C209-19. Epub 2002 Sep 11.

Supplemental Content

Loading ...
Support Center